explore -WSS

explore

author：knowledge 2025-09-27 22:05:46 - browse：78961

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： The stability of $0 premiums in Medicare Advantage

leisure time

WSS

Timeline: Special counsel's investigation into Trump's handling of classified documents

Congress extends some pandemic preparedness programs

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

European officials brace for rough respiratory virus season

Where are patients getting their prescriptions for GLP

leisure time

explore

leisure time

Bright Health sells Medicare Advantage business to Molina

Kim Kardashian sparks debate on benefits of full

At least 13 dead in Texas as scorching temps continue

Study points to new risk in gene therapy death of Terry Horgan

BioMarin wins approval for gene therapy to treat hemophilia A

RSV injection headlines need to be accurate for good uptake

Activists slam private health insurers over coverage restrictions

The United States is paying nearly triple for new Covid vaccines

Trump demands the U.S. pay no more for drugs than other countries … again

Setback for rare diseases as Taysha Gene Therapies pulls back

focus

The history of OxyContin, told through Purdue Pharma documents

Maui funeral service workers on devastation of fires: 'I'm in shock'

The history of OxyContin, told through Purdue Pharma documents

Some top drug companies are starting to take action on climate

Nobel honors Karikó and Weissman's enduring partnership

CRISPR base editing slashes cholesterol levels in monkeys

entertainment

knowledge

leisure time

knowledge